Individualization of Irinotecan Treatment: A Review of Pharmacokinetics, Pharmacodynamics, and Pharmacogenetics von de Man, Femke M., Goey, Andrew K. L., van Schaik, Ron H. N., Mathijssen, Ron H. J., Bins, Sander

Volltext

Contribution of Organic Cation Transporter 2 (OCT2) to Cisplatin‐Induced Nephrotoxicity von Filipski, K K, Mathijssen, R H, Mikkelsen, T S, Schinkel, A H, Sparreboom, A

Volltext

Drug–drug interactions with tyrosine-kinase inhibitors: a clinical perspective von van Leeuwen, Roelof W F, PharmD, van Gelder, Teun, Prof, Mathijssen, Ron H J, Prof, Jansman, Frank G A, Dr

Volltext

Cross-resistance between taxanes and new hormonal agents abiraterone and enzalutamide may affect drug sequence choices in metastatic castration-resistant prostate cancer von van Soest, R.J, van Royen, M.E, de Morrée, E.S, Moll, J.M, Teubel, W, Wiemer, E.A.C, Mathijssen, R.H.J, de Wit, R, van Weerden, W.M

Volltext

Therapeutic drug monitoring in oncology: International Association of Therapeutic Drug Monitoring and Clinical Toxicology consensus guidelines for imatinib therapy von Clarke, William A., Chatelut, Etienne, Fotoohi, Alan K., Larson, Richard A., Martin, Jennifer H., Mathijssen, Ron H.J., Salamone, Salvatore J.

Volltext

Olaparib combined with chemotherapy for recurrent platinum-sensitive ovarian cancer: a randomised phase 2 trial von Oza, Amit M, Prof, Cibula, David, Prof, Benzaquen, Ana Oaknin, MD, Poole, Christopher, Prof, Mathijssen, Ron H J, Prof, Sonke, Gabe S, MD, Colombo, Nicoletta, MD, Špaček, Jiří, MD, Vuylsteke, Peter, MD, Hirte, Holger, MD, Mahner, Sven, MD, Plante, Marie, MD, Schmalfeldt, Barbara, Prof, Mackay, Helen, MD, Rowbottom, Jacqui, PhD, Lowe, Elizabeth S, MD, Dougherty, Brian, PhD, Barrett, J Carl, PhD, Friedlander, Michael, Prof

Volltext

Therapeutic Drug Monitoring in Oncology: International Association of Therapeutic Drug Monitoring and Clinical Toxicology Recommendations for 5‐Fluorouracil Therapy von Beumer, Jan H., Chu, Edward, Allegra, Carmen, Tanigawara, Yusuke, Milano, Gerard, Diasio, Robert, Kim, Tae Won, Mathijssen, Ron H., Zhang, Li, Arnold, Dirk, Muneoka, Katsuki, Boku, Narikazu, Joerger, Markus

Volltext

Individualized dosing of oral targeted therapies in oncology is crucial in the era of precision medicine von Groenland, Stefanie L., Mathijssen, Ron H. J., Beijnen, Jos H., Huitema, Alwin D. R., Steeghs, Neeltje

Volltext

Prevalence of potential drug–drug interactions in cancer patients treated with oral anticancer drugs von van Leeuwen, R W F, Brundel, D H S, Neef, C, van Gelder, T, Mathijssen, R H J, Burger, D M, Jansman, F G A

Volltext

Tumor mutational load, CD8+ T cells, expression of PD-L1 and HLA class I to guide immunotherapy decisions in NSCLC patients von Hurkmans, Daan P., Kuipers, Merian E., Smit, Jasper, van Marion, Ronald, Mathijssen, Ron H. J., Postmus, Piet E., Hiemstra, Pieter S., Aerts, Joachim G. J. V., von der Thüsen, Jan H., van der Burg, Sjoerd H.

Volltext

Applying a cost-based pricing model for innovative cancer treatments subject to indication expansion: A case study for pembrolizumab and daratumumab von Heine, R J S D, Thielen, F W, Mathijssen, R H J, van Leeuwen, R W F, Franken, M G, Uyl-de Groot, C A

Volltext

miR-141 regulates KEAP1 and modulates cisplatin sensitivity in ovarian cancer cells von van Jaarsveld, M T M, Helleman, J, Boersma, A W M, van Kuijk, P F, van IJcken, W F, Despierre, E, Vergote, I, Mathijssen, R H J, Berns, E M J J, Verweij, J, Pothof, J, Wiemer, E A C

Volltext

Physiologically based pharmacokinetic/pharmacodynamic model for the prediction of morphine brain disposition and analgesia in adults and children von Verscheijden, Laurens F M, Litjens, Carlijn H C, Koenderink, Jan B, Mathijssen, Ron H J, Verbeek, Marcel M, de Wildt, Saskia N, Russel, Frans G M

Volltext

Proximal Tubular Secretion of Creatinine by Organic Cation Transporter OCT2 in Cancer Patients von CIARIMBOLI, Giuliano, LANCASTER, Cynthia S, PUI, Ching-Hon, RELLING, Mary V, HERRMANN, Edwin, SPARREBOOM, Alex, SCHLATTER, Eberhard, FRANKE, Ryan M, SPROWL, Jason A, PAVENSTÄDT, Hermann, MASSMANN, Vivian, GUCKEL, Denise, MATHIJSSEN, Ron H. J, WENJIAN YANG

Volltext

Recent Clinical Developments of Nanomediated Drug Delivery Systems of Taxanes for the Treatment of Cancer von van Eerden, Ruben A G, Mathijssen, Ron H J, Koolen, Stijn L W

Volltext

Clinically relevant drug interactions with multikinase inhibitors: a review von Hussaarts, Koen G. A. M., Veerman, G. D. Marijn, Jansman, Frank G. A., van Gelder, Teun, Mathijssen, Ron H. J., van Leeuwen, Roelof W. F.

Volltext

Effects of St. John's Wort on Irinotecan Metabolism von Mathijssen, Ron H. J., Verweij, Jaap, de Bruijn, Peter, Loos, Walter J., Sparreboom, Alex

Volltext

Treatment of Hypertension and Renal Injury Induced by the Angiogenesis Inhibitor Sunitinib: Preclinical Study von Lankhorst, Stephanie, Kappers, Mariëtte H.W, van Esch, Joep H.M, Smedts, Frank M.M, Sleijfer, Stefan, Mathijssen, Ron H.J, Baelde, Hans J, Danser, A.H Jan, van den Meiracker, Anton H

Volltext

A review of factors explaining variability in fentanyl pharmacokinetics; focus on implications for cancer patients von Kuip, Evelien J. M., Zandvliet, Maarten L., Koolen, Stijn L. W., Mathijssen, Ron H. J., Rijt, Carin C. D.

Volltext

Is uracil enough for effective pre-emptive DPD testing? von Heersche, Niels, Matic, Maja, Mathijssen, Ron H.J., Coenen, Marieke J.H., van Schaik, Ron H.N.

Volltext